Hu Zhanghong, chief executive of CCB International (Holdings) Co., Ltd., disclosed on the first China Health Industry Investment Summit in China recently that since November last year, CCB International has been stepping up preparations for the establishment of a Chinese healthcare investment fund, which will be the first in China. The company focuses on corporate investment funds that invest in the healthcare industry.
Hu Zhanghong introduced that the China Healthcare Investment Fund was led by CCB International, and the initial scale will not exceed RMB 5 billion. The main investment directions of the fund are: pharmaceutical industry, medical instrument equipment industry, medical institutions, medical service industry, rehabilitation and health care industry.
When talking about the reasons for investing in the health industry, Hu Zhanghong said that under the background of China's sustained economic growth, medical insurance investment has become the focus of government transfer payments, and the time for the operation of China's healthcare industry investment fund to coincide with the start of medical reform will be highly shared. The high growth of China's health industry.
He also pointed out that the health industry is rich in profits. In 2002, among Fortune Global 500 companies, there were 10 health medicine companies. The sum of profits of these 10 companies was 35.9 billion U.S. dollars, equivalent to the sum of profits of 490 other companies.
At the same time, the health industry also has a huge investment return space. Hu Zhanghong said that Genentech is a biopharmaceutical company engaged in the production of monoclonal antibodies. The company’s stock price was around US$6 in 1996. After the company gradually became the industry’s most important monoclonal antibody drug R&D company, its stock price exceeded 90 in 2005. Dollars. The company’s stock price has increased 15 times in ten years, and the average annual return on investment has reached 1.5 times.
CCB International is a wholly-owned overseas investment bank of China Construction Bank. It is mainly based on Hong Kong, relying on the Mainland, and developing a diversified investment banking business for the international capital market.
The first China Health Industry Investment Summit Forum was jointly organized by the Chinese Medical Association, the China Health Promotion Foundation and the Health 863 Network. It is reported that from 2008 onwards, the Forum will be held regularly every year to promote the development of China's health industry financing investment.
Machining Stainless steel is the use of CNC machining out, including drilling, boring, cutting, turning, screw, etc.. Machining stainless steel commonly used materials: sus303304316.stainless steel has a very high hardness after machining, easy deformation, so in the process of rough machining to eliminate stress, and then finished. Surface treatment is generally passivation, we have specialized laboratories to test products, and ensure that each size to meet the requirements of the drawings, including the machining stainless steel application in various industries: automobile, ship, crane, medical equipment, industrial automation equipment.
Of course,we also accept the custom machining,welcome to contact us.
Machining Stainless Steel,High Precision Machining Stainless Steel,Cnc Machining Stainless Steel,Stainless Steel Machining,Steel Machining
Hong Kong RYH CO., LTD , https://www.szcncturning.com